What is the Share Price of Gujarat Themis Biosyn Ltd?
- Answer Field
-
The share price of Gujarat Themis Biosyn Ltd for NSE is ₹ 273.9 and for BSE is ₹ 277.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, GUJARAT THEMIS BIOSYN LTD share price is currently at ₹ 273.9, which is down by ₹ -10.80 from its previous closing. Today, the stock has fluctuated between ₹ 273.10 and ₹ 288.80. Over the past year, GUJARAT THEMIS BIOSYN LTD has achieved a return of 0.00 %. In the last month alone, the return has been 4.66 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 39.52 |
Operating Expense | 22.36 |
Net Profit | 12.97 |
Net Profit Margin (%) | 32.81 |
Earnings Per Share (EPS) | 1.19 |
EBITDA | 19.09 |
Effective Tax Rate (%) | 25.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 19.95 | 2.02 | 284.31 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 122.65 | 16.07 | 1.27 | 1292.37 | 92.25 / 184.95 |
CIPLA LTD | 1541.00 | 24.94 | 4.38 | 124457.39 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 272.25 | 22.56 | 2.76 | 801.26 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2904.45 | 57.61 | 29.41 | 49203.14 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 22.35 | 6.30 | 284.31 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 679.10 | 39.81 | 6.59 | 1963.32 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8795.90 | 131.18 | 32.36 | 21989.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 122.65 | 15.93 | 1.26 | 1292.37 | 92.25 / 184.95 |
Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL.
During 1995-96 the paid-up share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year installed capacity of rifamysin-S was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of anti-tuberculosis products and other antibiotics.
The company is constantly identifying new areas for diversification and also capacity expansion of exisiting product in order to further reduction in cost of production and increase in turnover.
The share price of Gujarat Themis Biosyn Ltd for NSE is ₹ 273.9 and for BSE is ₹ 277.
The market cap of Gujarat Themis Biosyn Ltd for NSE is ₹ 30,08.00 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Gujarat Themis Biosyn Ltd for NSE is ₹ 330.45 and ₹ 208.00 and for BSE is ₹ 390.00 and ₹ 192.35.
You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 0.00%.
Gujarat Themis Biosyn Ltd share price is for NSE ₹ 273.9 & for BSE ₹ 277 as on Apr 30 2025 03:29 PM.
The market cap of Gujarat Themis Biosyn Ltd for NSE ₹ 30,08.00 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.
As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Gujarat Themis Biosyn Ltd share is 59.04.
As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Gujarat Themis Biosyn Ltd share is 20.50.
You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a demat account.
To buy Gujarat Themis Biosyn Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Gujarat Themis Biosyn Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found